来自MSN3 个月
MeMed’s sepsis test receives FDA breakthrough device status
MeMed has received breakthrough device designation (BDD) from the US Food and Drug Administration (FDA) for its MeMed Severity test, designed to enhance the management of patients with suspected ...
来自MSN2 个月
Anumana and AliveCor to co-develop AI algorithms for cardiac disease detection
In June 2023, the ECG-AI algorithm received breakthrough device designation (BDD) from the FDA. "Anumana and AliveCor to co-develop AI algorithms for cardiac disease detection" was originally ...